Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Non-cash Items (2019 - 2024)

Historic Non-cash Items for Harvard Bioscience (HBIO) over the last 6 years, with Q3 2024 value amounting to $28000.0.

  • Harvard Bioscience's Non-cash Items changed N/A to $28000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $28000.0, marking a year-over-year change of. This contributed to the annual value of $1.8 million for FY2023, which is 86631.58% up from last year.
  • Per Harvard Bioscience's latest filing, its Non-cash Items stood at $28000.0 for Q3 2024.
  • Over the past 5 years, Harvard Bioscience's Non-cash Items peaked at $5.6 million during Q4 2021, and registered a low of $28000.0 during Q3 2024.
  • Over the past 5 years, Harvard Bioscience's median Non-cash Items value was $964000.0 (recorded in 2024), while the average stood at $1.6 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first skyrocketed by 87003.89% in 2020, then plummeted by 9657.84% in 2022.
  • Quarter analysis of 5 years shows Harvard Bioscience's Non-cash Items stood at $2.5 million in 2020, then skyrocketed by 122.74% to $5.6 million in 2021, then crashed by 96.58% to $190000.0 in 2022, then skyrocketed by 866.32% to $1.8 million in 2023, then crashed by 98.47% to $28000.0 in 2024.
  • Its Non-cash Items was $28000.0 in Q3 2024, compared to $91000.0 in Q2 2024 and $964000.0 in Q1 2024.